Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127240941 | 12724094 | 1 | I | 2011 | 20160728 | 20160908 | 20160908 | EXP | US-SA-2016SA150399 | AVENTIS | 63.00 | YR | A | M | Y | 0.00000 | 20160908 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127240941 | 12724094 | 1 | SS | LASIX | FUROSEMIDE | 1 | Unknown | Y | UNKNOWN | 0 | |||||||||
| 127240941 | 12724094 | 2 | PS | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Unknown | U | UNKNOWN | 20839 | |||||||||
| 127240941 | 12724094 | 3 | SS | TORSEMIDE. | TORSEMIDE | 1 | Unknown | U | UNKNOWN | 0 |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127240941 | 12724094 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127240941 | 12724094 | Amino acid level abnormal | |
| 127240941 | 12724094 | Cardiac failure congestive | |
| 127240941 | 12724094 | Fluid retention | |
| 127240941 | 12724094 | High density lipoprotein increased | |
| 127240941 | 12724094 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127240941 | 12724094 | 1 | 2011 | 0 | ||
| 127240941 | 12724094 | 2 | 2011 | 0 | ||
| 127240941 | 12724094 | 3 | 2011 | 0 |